Lehnen joins Watson to help with Actavis
This article was originally published in Scrip
Executive Summary
Watson Pharmaceuticals has appointed Dr Marc Lehnen to the newly created position of senior vp, global integration management, in light of the company's intention to acquire Swiss firm Actavis. Dr Lehnen will head up the global integration management office at Watson which will focus on planning and implementing the integration of Actavis. He will join Watson on 1 July following ten years with McKinsey & Company, most recently as a partner.